A UK-based manufacturer specializing in cell line controls for slide-based assessments in Immunohistochemistry (IHC) and in situ hybridization (ISH).Key Achievements: ★ Spearheading commercial strategies for the UK, US, and Europe regions.★ Collaborating closely with R&D to align product offerings with market demands.★ Pioneering initiatives for market penetration and brand recognition.

An esteemed institution fostering innovation in the field of biomedical engineering.Key Achievements: ★ Offering strategic guidance on curriculum developments, research directions and industrial collaborations.★ Bridging academia with real-world clinical and industrial challenges.★ Enhancing the synergy between industry needs and academic offerings.

SurgiTech Ltd. is a medical device consultancy company providing market access, product development, and business development expertise across the UK and European healthcare systems. Special Assignments:1. HD Technologies: A Premium French provider of the latest Oncology and Radiotherapy healthcare products in the French market. I was appointed as a consultant to investigate market access opportunities post-Brexit in the UK market.Key Achievements: ★ Mapped the new NHS organisations to understand the decision-making units for financial, clinical, procurement, and operations★ Identified new customers, built NHS procurement relationships, presented a business plan and commercialised and launched a portfolio of products in the UK____2. Clarity Global Group: A British company with revenues over €100m and recognised as one of the fastest-growing businesses won the "Pharma Fast 50" in 2020 in recognition of its outstanding growth. I was appointed as Managing Director to build a new medical device division. Key Achievements:★ Built an EU distributor diagnostic and engaged targeted distributors★ Created clinical evaluation protocols★ Negotiated pricing agreements★ Introduced the UK and European tender process and completed tenders valued at more than $35m___3. Varian: Following the sale of Boston Scientific's microsphere portfolio to Varian, I was appointed to transfer the portfolio to a new interventional oncology division and establish a business-to-business sales channel.Key Achievements:★ Strengthened Varian's oncology business worth over $2.5 million p.a★ Completed intensive due diligence and onboarded new EMEA distributors★ Led commercial negotiations and penetrated the marketplace★ Prospected and identified commercial opportunities within a dynamic international territory4. OrganLike Ltd: A British Company producing "hyper-real" organ models and tools for surgical simulation, medical training and the medical device industry.

Angiodynamics is an American manufacturer of vascular, peripheral vascular, and oncology products, employing over 1,200 employees.As a result of AngioDynamics’ fluid management portfolio divestment, appointed to resize the remaining business and seized the opportunity to embed ‘one AngioDynamics’ culture, placed talent at the centre of business, combined three business units into one, and executed strategic plans that increased sales and margin enhancement. I reported directly to the Senior Vice President in the US business.

Promoted to head up Vascular Access (VA) and Vascular Intervention Technologies (VIT) business units. Achieved unprecedented growth of 51% (VA) and 16% (VIT) and doubled revenue in two years. Uplifted margin enhancement by two points, delivered cultural shift and optimised business landscape. I reported directly to the Senior Vice President of the Vascular Interventional Therapies Division.Key Achievements★ Developed and installed an operational distributor ‘traffic light system’ management tool, which doubled sales revenue in the Vascular Access division and provided +16% year-on-year growth in the Vascular Interventional Technology division★ Transformed our distributor relationships from transactional to true partnerships★ Delivered a go-to-market strategy (direct versus distributor), resulting in year-over-year growth of +23%

Rose to the challenge and turned around an underperforming regional business unit. Immediately reviewed the entire operation and assessed strategic and commercial needs. Reconnected with customers through ‘hands-on’ leadership approach, upskilled talent pool and embedded collaborative culture. I reported to the Regional Vice President of the EMEA.Key Achievements★ Motivated the team to overachieve a challenging budget and deliver an extra +13% in sales revenue★ Drove sales excellence through the introduction of a plan and review strategy

Blue Belt Technologies was an American manufacturer that developed and commercialised robotic-assisted technologies in orthopaedic surgery and other specialities—acquired by Smith and Nephew.Handpicked by the CEO for a new Orthopaedic Robotic MedTech start-up. Established world-class business and penetrated markets in EMEA and APAC. Grew venture into a multi-million-pound enterprise, secured regulatory approval, sourced leadership talent, created distributor network and oversaw the acquisition by Smith & Nephew. I reported directly to the Chief Executive Officer.Key Achievements★ Built a highly credible Scientific Advisory Board ★ Developed an educational tool called "Technology Days", 120 surgeons trained★ Built commercial alliances with major implant manufacturers★ Achieved all milestones, including $7.5m in revenue by year 4, contributing to a successful exit sold to Smith and Nephew for $275m in 2016

Smith and Nephew is an international manufacturer of advanced wound management products, arthroscopy products, trauma and clinical therapy products, and orthopaedic reconstruction products.Promoted up to Vice President EMEA based on the demonstrable track record of commercial success. Maximised regional opportunities and exceeded multi-million-dollar target through new customer initiative, established sales academy and significantly decreased customer churn and increased conversion rates. I reported directly to the President of the EMEA.Key Achievements★ Converted 1389 new customers achieving $76.9m (+15%) in incremental revenue★ Successfully introduced a customer retention programme and decreased customer churn by 3%★ launched European tender tracking tool, increased conversion rates by 2% and global transparency★ Built Sales Academy linking sales and sales leadership training to the new customer initiatives

Took control of European Hip Franchise and was an integral executive leadership team member, realised notable additional growth across the hip product portfolio, pioneered medical education vision alongside Chief Medical Officer (CMO), and launched the hip portfolio rationalisation programme. I reported directly to the President of the EMEA.Key Achievements★ Generated an increase of +5% revenue in the focus product category★ Introduced a product launch strategy for all hip products across the EMEA★ Established stakeholder support across the executive leadership team and all countries

Offered director-level position to transform and enhance the UK’s marketing capability. Outlined strategic plans, identified optimum product mix following intensive analysis, and drafted strategic objectives adopted as an international blueprint by the US Vice President of Marketing and other global units. I reported directly to the UK General Manager.Key Achievements★ Transformed UK marketing capability; formulated the strategic, marketing, and business plans★ Rationalised the product portfolio resulting in a +1% improvement in margin enhancement★ Successfully rolled out the commercial plan to align with the company vision

Covidien was an American Manufacturer of Minimally Invasive therapy products, including stapling, laparoscopy, sutures, and advanced energy-based surgical devices. Acquired by Medtronic.Key Achievements★ Portfolio responsibility of approximately $50 million★ Developed upstream marketing plans, which led to a growth of 3% in revenues across the Cardiovascular portfolio★ Launched new products and re-vitalised older categories

Key Achievements★ Strategically aligned training with the needs of the countries★ Trained over 100 new sales representatives, distributors and agents★ Built and introduced cardiovascular Master Classes linking the industry to Healthcare Professionals★ Trained over 50 new surgical residents★ Built, led and presented the company's first recertification programme for all sales representatives in the field

Computer Motion was an American manufacturer that developed and commercialised robotic-assisted technologies in vascular surgery and other specialities.Key Achievements★ Pioneered the sale of the Zeus MicroWrist Robotic Surgical System for minimally invasive surgical procedures, the Hermes voice control centre, the AESOP Robotic Endoscope Positioner and the Socrates Telecollaboration System across the EMEA★ Achieved all commercial milestones★ Successful start-up company exit, purchased by Intuitive Surgical 2003

Covidien was an American Manufacturer of Minimally Invasive therapy products, including stapling, laparoscopy, sutures, and advanced energy-based surgical devices. Acquired by MedtronicKey Achievements★ Achieved 24 consecutive quarterly sales targets★ Established the largest regional suture customer base in the UK★ Established a reputation as a consistent top-performer and multiple award winner, including "Presidents Club".